Pesquisar | ValuTok

KUMUD SINGH adicionou um novo artigo Health
2026-04-08 09:52:44

Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...

0 Comentários 0 Compartilhamentos 713 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
KUMUD SINGH adicionou um novo artigo Health
2026-04-08 09:53:28

Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...

0 Comentários 0 Compartilhamentos 694 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Komal Galande adicionou um novo artigo Causes
2026-04-29 05:16:22

Can Advancements in Vaccines Help Control Japanese Encephalitis Globally?
Japanese Encephalitis Market Summary: According to the latest report published by Data Bridge Market Research, the Japanese Encephalitis Market CAGR Value The winning Japanese Encephalitis Market report brings into focus the new highs that will be made by the Japanese Encephalitis Market industry in the forecast period 2020 - 2027. This market report lends a hand to Japanese...

0 Comentários 0 Compartilhamentos 775 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Mikel Watson adicionou um novo artigo Outro
2026-02-27 12:42:57

Human Papillomavirus Vaccine (HPV) Market Valuation to Touch US$ 7.71 Billion by 2034
The Human Papillomavirus (HPV) Vaccine is formulated using virus-like particles that mimic the outer protein structure of the virus without containing its genetic material. This design ensures strong immunogenicity while maintaining a high safety profile. By targeting specific high-risk and low-risk HPV strains, the vaccine effectively prevents infections that may otherwise progress to...

0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!